WKHS Locations

Clinical Trials

Study Title

MERCK V221

Purpose

To evaluate the safety, tolerability and immunogenicity of MMRV Vaccine (AMP) as compared to ProQuad in children 12-23 months of age

Eligibility

Contact Principal Investigator for Information

Study Process

Contact Principal Investigator for Information

Trial Details

Principal Investigator:

William Parker, M.D.

IRB:

Schulman

IRB Number:

Trial Type:

Drug

Sponsor:

Merck

Contact Information:

Portico Pediatrics
(318) 212-3930
http://www.porticopediatrics.com